244 related articles for article (PubMed ID: 17381636)
1. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
Bauzá G; Hirsch E; Burke P; Quillen K
Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
[No Abstract] [Full Text] [Related]
2. Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
Ganguly S; Spengel K; Tilzer LL; O'neal B; Simpson SQ
Clin Lab Haematol; 2006 Oct; 28(5):309-12. PubMed ID: 16999720
[TBL] [Abstract][Full Text] [Related]
3. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
5. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
6. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.
Clark AD; Gordon WC; Walker ID; Tait RC
Vox Sang; 2004 Feb; 86(2):120-4. PubMed ID: 15023181
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
[No Abstract] [Full Text] [Related]
8. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
9. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
Holcomb JB; Hoots K; Moore FA
Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
[TBL] [Abstract][Full Text] [Related]
10. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
Perkins JG; Schreiber MA; Wade CE; Holcomb JB
J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
[TBL] [Abstract][Full Text] [Related]
11. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
Benharash P; Bongard F; Putnam B
Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
[TBL] [Abstract][Full Text] [Related]
13. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
Stein DM; Dutton RP; Hess JR; Scalea TM
Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
[TBL] [Abstract][Full Text] [Related]
14. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage.
Harrison TD; Laskosky J; Jazaeri O; Pasquale MD; Cipolle M
J Trauma; 2005 Jul; 59(1):150-4. PubMed ID: 16096555
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant factor VIIa in trauma patients.
Talbot M; Tien HC
J Am Acad Orthop Surg; 2009 Aug; 17(8):477-81. PubMed ID: 19652029
[No Abstract] [Full Text] [Related]
16. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII (Novoseven) in trauma and surgery: analysis of outcomes reported to an international registry.
Grounds RM; Seebach C; Knothe C; Paluszkiewicz P; Smith TS; Kasal E; Lecumberri R; Urbanec R; Haas T; Wujtewicz M; Rehorkova D; Pelichovska M; Lange M; Uranga M; Bosman R; Rommes JH; Koscielny J
J Intensive Care Med; 2006; 21(1):27-39. PubMed ID: 16698742
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Levi M; Peters M; Büller HR
Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.
Holcomb JB
J Trauma; 2005 Jun; 58(6):1298-303. PubMed ID: 15995488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
